BUTTERFLY NETWORK INC CLASS A (BFLY)
Health Care · Point-of-care ultrasound imaging devices · NYSE
Butterfly Network commercializes portable ultrasound imaging devices using proprietary Ultrasound-on-Chip technology to bring point-of-care diagnostics to non-traditional settings.
What BUTTERFLY NETWORK INC CLASS A does
Butterfly Network develops and commercializes portable ultrasound imaging devices based on its proprietary Ultrasound-on-Chip technology. The company's primary products are the Butterfly iQ+ and Butterfly iQ3 point-of-care ultrasound imaging devices launched in 2020 and 2024, respectively. The company also generates revenue through licensing its Ultrasound-on-Chip technology to third parties and through enterprise software offerings.
Themes: ["point-of-care ultrasound imaging"]
Fundamentals
- Price$8.02 as of 2026-07-09 close
- Market cap$1.9B as of 2026-07-10
- 1-year return+311.3% as of 2026-07-09 close
- Net margin-73.7% as of 2026-07-10
- Gross margin+49.2% as of 2026-07-10
- ROE-36.8% as of 2026-07-10
- Debt / equity0.00 as of 2026-07-10
- Revenue growth (YoY)+20.2% as of 2026-07-10
- Revenue CAGR (3y)+10.0% SEC XBRL
- Beta2.09 as of 2026-07-10
Key risks (from latest filing)
["Company has incurred significant cumulative net losses ($879.2 million accumulated deficit as of December 31, 2025) and is unprofitable with continued losses expected for at least several years."]
Competitors & peers
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.